Jeffrey Henley - 23 Sep 2021 Form 4 Insider Report for ORACLE CORP (ORCL)

Role
Executive Vice Chairman, Director
Signature
/s/ Rebecca A. Isakson By Rebecca A. Isakson, Attorney in Fact for Jeffrey Henley (POA Filed 03/20/19)
Issuer symbol
ORCL
Transactions as of
23 Sep 2021
Net transactions value
-$14,671,378
Form type
4
Filing time
24 Sep 2021, 21:03:00 UTC
Previous filing
05 Aug 2021
Next filing
28 Sep 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ORCL Common Stock Options Exercise $3,198,585 +107,624 +5.8% $29.72 1,948,626 23 Sep 2021 by Trust
transaction ORCL Common Stock Sale $9,686,709 -107,624 -5.5% $90.01 1,841,002 23 Sep 2021 by Trust F1, F2
transaction ORCL Common Stock Options Exercise $4,034,223 +135,741 +7.4% $29.72 1,976,743 24 Sep 2021 by Trust
transaction ORCL Common Stock Sale $12,217,477 -135,741 -6.9% $90.01 1,841,002 24 Sep 2021 by Trust F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ORCL Stock Option Options Exercise $0 -107,624 -27% $0.000000 292,376 23 Sep 2021 Common Stock 107,624 $29.72 Direct F3
transaction ORCL Stock Option Options Exercise $0 -135,741 -46% $0.000000 156,635 24 Sep 2021 Common Stock 135,741 $29.72 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of shares pursuant to Rule 10b5-1 Plan adopted on July 22, 2021.
F2 This transaction was executed in multiple trades at prices ranging from $90.00 to $90.06. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 25% of the shares subject to the option vested annually on each anniversary of the grant date.